Answers are grounded in this paper and cite their sources.
Psychosis is a heterogeneous syndrome with a highly variable prognosis where treatment refractory and relapsing courses are all too common. We and others have been studying abnormal immunological markers in patients with first-episode psychosis. Recently, the recognition and description of autoimmune encephalitis associated with antibodies against N-methyl-d-aspartate neurotransmitter cell surface receptors (NMDAR) have provided evidence that abnormalities in immune response may be responsible for a small but important subgroup of patients with acute psychosis.
No takes yet. Share an insight, caveat, or question.
Scott et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: